Dual-Drug ADC Synthesis Using a Combination of Nonnatural Amino Acid and Cysteine-Based Conjugations

Authors: Long, Bonnie; Owen, Shawn C

Source journal: Methods in molecular biology (Clifton, N.J.) (2027-01-01)

DOI: 10.1007/978-1-0716-5719-5_7

Abstract

Antibody-drug conjugates (ADCs) require controlled conjugation strategies to achieve defined drug-to-antibody ratios (DAR) and maintain favorable biophysical and functional properties. Here, we describe a modular workflow for the generation and characterization of site-specifically conjugated ADCs using a cyclopentadiene-containing noncanonical amino acid incorporated into IgG1 antibodies, followed by conjugation via inverse-electron-demand Diels-Alder chemistry. This approach enables selective modification at predefined sites and can be combined with conventional cysteine-based thiol-Michael addition to access complementary conjugation modalities. We describe detailed procedures for antibody expression in mammalian cells, purification, conjugation with a panel of drug-linkers, and analytical characterization by mass spectrometry. This platform supports the generation of ADCs with tunable DAR and composition and is compatible with a range of payload-linker constructs.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.